Clinical and Experimental Reproductive Medicine

  • 제41권3호
  • /
  • Pages.140-145
  • /
  • 2014
  • /
  • 2233-8233(pISSN)
  • /
  • 2233-8241(eISSN)
대한생식의학회 (The Korean Society for Reproductive Medicine)
권호 표지
DOI QR코드

DOI QR Code

Spontaneous ovarian hyperstimulation syndrome following a thawed embryo transfer cycle

  • Kim, Mi Kyoung (Fertility Center of CHA Gangnam Medical Center, CHA Gangnam Medical Center, CHA University) ;
  • Won, Hyung Jae (Fertility Center of CHA Gangnam Medical Center, CHA Gangnam Medical Center, CHA University) ;
  • Shim, Sung Han (Fertility Center of CHA Gangnam Medical Center, CHA Gangnam Medical Center, CHA University) ;
  • Cha, Dong Hyun (Department of Obstetrics and Gynecology, CHA Gangnam Medical Center, CHA University) ;
  • Yoon, Tae Ki (Fertility Center of CHA Gangnam Medical Center, CHA Gangnam Medical Center, CHA University)
  • 투고 : 2014.07.21
  • 심사 : 2014.09.11
  • 발행 : 2014.09.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

This article reports a case of spontaneous ovarian hyperstimulation syndrome (OHSS) following a thawed embryo transfer cycle. OHSS, a potentially life-threatening condition, is an iatrogenic complication of controlled ovarian stimulation; therefore, it is very important to prevent and treat OHSS during treatment with ovulation-inducing agents. Despite our efforts to prevent OHSS, in this case, severe spontaneous OHSS occurred, which resulted in uncontrolled preterm labor and a preterm delivery and also persisted for 6 weeks after delivery. Freezing all embryos cannot entirely prevent the development of OHSS because OHSS can occur spontaneously. Although spontaneous OHSS remains a rare event, females with a history of OHSS may have an elevated risk for spontaneous OHSS. We suggest closely monitoring cases of pregnancy following thawed embryo transfer for early diagnosis of spontaneous OHSS and the use of conservative management.

키워드

참고문헌

  1. Delvigne A, Rozenberg S. Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review. Hum Reprod Update 2002;8:559-77. https://doi.org/10.1093/humupd/8.6.559
  2. Smitz J, Camus M, Devroey P, Erard P, Wisanto A, Van Steirteghem AC. Incidence of severe ovarian hyperstimulation syndrome after GnRH agonist/HMG superovulation for in-vitro fertilization. Hum Reprod 1990;5:933-7. https://doi.org/10.1093/oxfordjournals.humrep.a137223
  3. Roest J, Mous HV, Zeilmaker GH, Verhoeff A. The incidence of major clinical complications in a Dutch transport IVF programme. Hum Reprod Update 1996;2:345-53. https://doi.org/10.1093/humupd/2.4.345
  4. Abramov Y, Elchalal U, Schenker JG. Severe OHSS: An 'epidemic' of severe OHSS: a price we have to pay? Hum Reprod 1999;14:2181-3. https://doi.org/10.1093/humrep/14.9.2181
  5. Andersen AN, Gianaroli L, Felberbaum R, de Mouzon J, Nygren KG; European IVF-monitoring programme (EIM), et al. Assisted reproductive technology in Europe, 2001. Results generated from European registers by ESHRE. Hum Reprod 2005;20:1158-76. https://doi.org/10.1093/humrep/deh755
  6. Cluroe AD, Synek BJ. A fatal case of ovarian hyperstimulation syndrome with cerebral infarction. Pathology 1995;27:344-6. https://doi.org/10.1080/00313029500169273
  7. Semba S, Moriya T, Youssef EM, Sasano H. An autopsy case of ovarian hyperstimulation syndrome with massive pulmonary edema and pleural effusion. Pathol Int 2000;50:549-52. https://doi.org/10.1046/j.1440-1827.2000.01082.x
  8. Braat DD, Schutte JM, Bernardus RE, Mooij TM, van Leeuwen FE. Maternal death related to IVF in the Netherlands 1984-2008. Hum Reprod 2010;25:1782-6. https://doi.org/10.1093/humrep/deq080
  9. Delbaere A, Bergmann PJ, Gervy-Decoster C, Deschodt-Lanckman M, de Maertelaer V, Staroukine M, et al. Increased angiotensin II in ascites during severe ovarian hyperstimulation syndrome: role of early pregnancy and ovarian gonadotropin stimulation. Fertil Steril 1997;67:1038-45. https://doi.org/10.1016/S0015-0282(97)81436-7
  10. Levin ER, Rosen GF, Cassidenti DL, Yee B, Meldrum D, Wisot A, et al. Role of vascular endothelial cell growth factor in Ovarian Hyperstimulation Syndrome. J Clin Invest 1998;102:1978-85. https://doi.org/10.1172/JCI4814
  11. Elchalal U, Schenker JG. The pathophysiology of ovarian hyperstimulation syndrome--views and ideas. Hum Reprod 1997;12:1129-37. https://doi.org/10.1093/humrep/12.6.1129
  12. Shapiro BS, Daneshmand ST, Garner FC, Aguirre M, Ross R, Morris S. Effects of the ovulatory serum concentration of human chorionic gonadotropin on the incidence of ovarian hyperstimulation syndrome and success rates for in vitro fertilization. Fertil Steril 2005;84:93-8. https://doi.org/10.1016/j.fertnstert.2004.12.053
  13. Garcia-Velasco JA, Zuniga A, Pacheco A, Gomez R, Simon C, Remohi J, et al. Coasting acts through downregulation of VEGF gene expression and protein secretion. Hum Reprod 2004;19:1530-8. https://doi.org/10.1093/humrep/deh298
  14. Shapiro BS, Daneshmand ST, Garner FC, Aguirre M, Ross R. Comparison of human chorionic gonadotropin and gonadotropinreleasing hormone agonist for final oocyte maturation in oocyte donor cycles. Fertil Steril 2007;88:237-9. https://doi.org/10.1016/j.fertnstert.2006.11.069
  15. Garcia-Velasco JA. Agonist trigger: what is the best approach? Agonist trigger with vitrification of oocytes or embryos. Fertil Steril 2012;97:527-8. https://doi.org/10.1016/j.fertnstert.2011.12.010
  16. Papanikolaou EG, Humaidan P, Polyzos N, Kalantaridou S, Kol S, Benadiva C, et al. New algorithm for OHSS prevention. Reprod Biol Endocrinol 2011;9:147. https://doi.org/10.1186/1477-7827-9-147
  17. Oztekin O, Soylu F, Tatli O. Spontaneous ovarian hyperstimulation syndrome in a normal singleton pregnancy. Taiwan J Obstet Gynecol 2006;45:272-5. https://doi.org/10.1016/S1028-4559(09)60241-2
  18. Lee DR, Yang YH, Eum JH, Seo JS, Ko JJ, Chung HM, et al. Effect of using slush nitrogen (SN2) on development of microsurgically manipulated vitrified/warmed mouse embryos. Hum Reprod 2007;22:2509-14. https://doi.org/10.1093/humrep/dem206
  19. Delvigne A, De Sutter P, Dhont M, Gerris J, Olivennes F, Nygren KG. Ovarian hyperstimulation syndrome guidelines [Internet]. 2013 [cited 2014 Sep 20]. Available from: http://www.gynera.ro/ wp-content/uploads/2013/03/OHSS-LONG_GUIDELINES.pdf.
  20. Devroey P, Polyzos NP, Blockeel C. An OHSS-Free Clinic by segmentation of IVF treatment. Hum Reprod 2011;26:2593-7. https://doi.org/10.1093/humrep/der251
  21. Leis D, Richter K, Schmid K. Spontaneous hyperstimulation of the ovaries with luteal cysts and ascites during a twin pregnancy-extreme case of the syndrome of painfull early pregnancy (author's transl). Geburtshilfe Frauenheilkd 1978;38:1085-7.
  22. Borna S, Nasery A. Spontaneous ovarian hyperstimulation in a pregnant woman with hypothyroidism. Fertil Steril 2007;88:705.e1-3.
  23. Zalel Y, Orvieto R, Ben-Rafael Z, Homburg R, Fisher O, Insler V. Recurrent spontaneous ovarian hyperstimulation syndrome associated with polycystic ovary syndrome. Gynecol Endocrinol 1995;9:313-5. https://doi.org/10.3109/09513599509160465
  24. Ludwig M, Gembruch U, Bauer O, Diedrich K. Ovarian hyperstimulation syndrome (OHSS) in a spontaneous pregnancy with fetal and placental triploidy: information about the general pathophysiology of OHSS. Hum Reprod 1998;13:2082-7. https://doi.org/10.1093/humrep/13.8.2082
  25. Baba T, Endo T, Kitajima Y, Kamiya H, Moriwaka O, Saito T. Spontaneous ovarian hyperstimulation syndrome and pituitary adenoma: incidental pregnancy triggers a catastrophic event. Fertil Steril 2009;92:390.e1-3.
  26. Smits G, Olatunbosun O, Delbaere A, Pierson R, Vassart G, Costagliola S. Ovarian hyperstimulation syndrome due to a mutation in the follicle-stimulating hormone receptor. N Engl J Med 2003;349:760-6. https://doi.org/10.1056/NEJMoa030064
  27. Conway GS, Conway E, Walker C, Hoppner W, Gromoll J, Simoni M. Mutation screening and isoform prevalence of the follicle stimulating hormone receptor gene in women with premature ovarian failure, resistant ovary syndrome and polycystic ovary syndrome. Clin Endocrinol (Oxf) 1999;51:97-9. https://doi.org/10.1046/j.1365-2265.1999.00745.x
  28. Simoni M, Gromoll J, Hoppner W, Kamischke A, Krafft T, Stahle D, et al. Mutational analysis of the follicle-stimulating hormone (FSH) receptor in normal and infertile men: identification and characterization of two discrete FSH receptor isoforms. J Clin Endocrinol Metab 1999;84:751-5.
  29. Sudo S, Kudo M, Wada S, Sato O, Hsueh AJ, Fujimoto S. Genetic and functional analyses of polymorphisms in the human FSH receptor gene. Mol Hum Reprod 2002;8:893-9. https://doi.org/10.1093/molehr/8.10.893
  30. Loutradis D, Patsoula E, Minas V, Koussidis GA, Antsaklis A, Michalas S, et al. FSH receptor gene polymorphisms have a role for different ovarian response to stimulation in patients entering IVF/ICSI-ET programs. J Assist Reprod Genet 2006;23:177-84. https://doi.org/10.1007/s10815-005-9015-z
  31. Perez Mayorga M, Gromoll J, Behre HM, Gassner C, Nieschlag E, Simoni M. Ovarian response to follicle-stimulating hormone (FSH) stimulation depends on the FSH receptor genotype. J Clin Endocrinol Metab 2000;85:3365-9.
  32. Daelemans C, Smits G, de Maertelaer V, Costagliola S, Englert Y, Vassart G, et al. Prediction of severity of symptoms in iatrogenic ovarian hyperstimulation syndrome by follicle-stimulating hormone receptor Ser680Asn polymorphism. J Clin Endocrinol Metab 2004;89:6310-5. https://doi.org/10.1210/jc.2004-1044

피인용 문헌

  1. Ovarian hyperstimulation syndrome in a frozen-thawed embryo transfer pregnancy: a rare case report vol.20, pp.1, 2014, https://doi.org/10.1186/s12884-020-03014-7
  2. Indications for Abdominal Surgery in Spontaneous Ovarian Hyperstimulation: A Literature Review vol.36, pp.6, 2014, https://doi.org/10.1089/gyn.2018.0096